Prof. Li Zhiqiang, Vice General Manager and Dean of Research Institute at Borns Medical Robotics, to Speak at MTWF 2018 on Intelligent Healthcare Innovation

Hosted by VCBeat, Eggshell Research Institute, and the Industry-Academia-Research Cooperation Coordination Department of the China High-Tech Industrialization Research Association“Infinity” – The 2018 World Forum on Medical Technology will be held at the Le Méridien Shanghai, Minhang Baolong Hotel on September 26–27.

Professor Li Zhiqiang, Deputy General Manager of Chengdu Borns Medical Robot Co., Ltd. and Dean of its Research Institute, has confirmed his attendance at the “Infinity” – 2018 World Forum on Medical Technology.

[Character Introduction]

Deputy General Manager and Dean of the Research Institute at Chengdu Borns Medical Robot Co., Ltd.; recipient of the Konrad-Adenauer-Stiftung Outstanding Young Scholar Award; Expert with Outstanding Contributions in Sichuan Province; Academic Leader in Sichuan Province. He has long been engaged in research in the fields of polymer materials, biomaterials, and biomedical engineering. He has presided over multiple National Key Technologies R&D Program projects and National High-Tech Research and Development Program (“863” Program) projects. He has received nine ministerial or provincial-level science and technology awards, holds six national invention patents, has published more than 50 academic papers in domestic and international journals, and authored two monographs.

Mr. Li Zhiqiang believes that “surgical robots” represent a high-tech integration, involvingRobotics, precision manufacturing technology, medical services, and artificial intelligence, among other multidisciplinary fields,This precisely reflects the characteristics of the new economy, which is defined by cross-sector integration driven primarily by innovation.

On September 27, Professor Li Zhiqiang, Deputy General Manager and Dean of the Research Institute at Chengdu Borns Medical Robot Co., Ltd., will attend the “Infinity” – 2018 World Forum on Medical Technology, co-hosted by VCBeat, VBInsight, and the Industry-University-Research Cooperation Coordination Department of the China High-Tech Industrialization Research Association. He will share insights on how to interpret smart healthcare in a more accessible and practical manner.

Scan the QR code to register. Early-bird tickets are on sale for a limited time...

[Conference Details]

We can now see that digital technologies such as artificial intelligence, robotics, 3D printing, and the Internet of Things are impacting various industries, with continuous technological innovation disrupting the healthcare sector.

With the introduction of the “Development Plan for New-Generation Artificial Intelligence” and the “Guiding Opinions on Promoting the Development of ‘Internet + Medical Health’,” capital has flooded into the sector, giving rise to numerous highly valued AI startups, while commercialization pathways continue to be explored.

The “Healthy China 2030” Planning Outline was released, and three major health and medical data groups were established; the explosive growth in data, driven by declining costs of data acquisition from gene sequencing and wearable devices, has laid a scalable foundation for big data and AI analytics.

With the growing acceptance of robotic applications in China’s healthcare sector and their widespread adoption across various stages of diagnosis and treatment, medical robots—particularly surgical robots—have become “high-demand products” within the robotics industry. Robotic systems are increasingly being deployed in hospitals, with domestic technologies steadily catching up to their foreign counterparts.

Medical 3D printing has entered a transition period from the primary to the intermediate stage. Applications such as dental restoration and customized prosthetics have already achieved commercialization and are developing rapidly. Orthopedics has become a key focus of market competition, attracting various enterprises to strategically position themselves. New breakthroughs have been made in organ and tissue experiments, making human clinical applications promising.

In April this year, the National Health Commission released the "Standards and Specifications for Hospital Information Construction in China (Trial)," which clearly defined 21 application scenarios for IoT-based positioning and data monitoring. With the introduction of these standards, the direction of the IoT industry has become increasingly clear, and scenario-based applications are beginning to stand out;

In the genetics sector, tumor detection is poised for rapid growth, microbiomics is gradually maturing under policy guidance, and consumer genetic testing has entered the “20-yuan era.”

Technological innovation enterprises have begun to explore their own paths for application implementation, scaling from 1 to N...

The 2018 World Forum on Medical Technology, themed “Infinity,” will be held at the Le Méridien Shanghai, Minhang from September 26 to September 27, 2018.

This forum will bring together domestic and international medical service providers, listed companies, financial institutions, and healthcare innovation enterprises that prioritize technological innovation. Discussions will center on five key dimensions: policy, capital, data, technology, and commercialization pathways. The event will explore the commercial applications of five major technologies—artificial intelligence, big data, robotics, 3D printing, and the Internet of Things (IoT), as well as genetic testing—within hospitals, pharmaceutical companies, and third-party medical service providers. The agenda features eight core forums covering more than 80 hot topics, and will gather over 80 distinguished guests, 100+ investors, 300+ entrepreneurs, and 30+ media outlets in Shanghai to spark intellectual exchange and foster collaboration.

If you are a government official, healthcare practitioner, or industry professional focused on technological innovation in health and medicine—including leaders from medical informatics companies, medical device manufacturers, pharmaceutical firms, insurance companies, industrial investors, healthcare media professionals, and executives of listed or startup companies engaged in big data and AI-driven healthcare—this industry forum is tailor-made for “you.”

You Are Only One Ticket Away from Industry Leaders

Scan the QR code to register. Limited-time early bird tickets available...